Erratum: Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery (JAMA - Journal of the American Medical Association (2013) 309:16 (1704-1713) DOI:10.1001/jama.2013.4135);Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery

JAMA

Volumn 309, Issue 16, 2013, Pages 1704-1713

  London, Martin J ^a   Hur, Kwan ^b   Schwartz, Gregory G ^c   Henderson, William G ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL SUCCINATE; METOPROLOL TARTRATE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART ARREST; HEART INFARCTION; HEART SURGERY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORBIDITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; POSTOPERATIVE STROKE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; Q WAVE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TREATMENT RESPONSE;

EID: 84876542468     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.6227     Document Type: Erratum

References (38)

1. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative beta blockers in patients having non-cardiac surgery: ameta-analysis. Lancet. 2008;372(9654):1962-1976.
2. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2009;120(21):e169- e276.
3. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353(4):349-361. (Pubitemid 41132339)
4. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-1049. (Pubitemid 29416229)
5. Wijeysundera DN, Mamdani M, Laupacis A, et al. Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery. Circ Cardiovasc Qual Outcomes. 2012;5(4):558-565.
6. Devereaux PJ, Yang H, Yusuf S, et al POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371(9627):1839-1847.
7. Bangalore S, Steg G, Deedwania P, et al REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13):1340-1349.
8. Khuri SF, Daley J, Henderson W, et al; National VA Surgical Quality Improvement Program. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peercontrolled program for the measurement and enhancement of the quality of surgical care. Ann Surg. 1998;228(4):491-507. (Pubitemid 30194393)
9. Davis CL, Pierce JR, Henderson W, et al. Assessment of the reliability of data collected for the Department of Veterans Affairs national surgical quality improvement program. J Am Coll Surg. 2007;204(4):550-560. (Pubitemid 46428566)
10. Sales MM, Cunningham FE, Glassman PA, Valentino MA, Good CB. Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003. Am J Manag Care. 2005;11(2):104-112. (Pubitemid 40250538)
11. Smith MW, Joseph GJ. Pharmacy data in the VA health care system. Med Care Res Rev. 2003;60(3)(suppl):92S-123S. (Pubitemid 36993497)
12. Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004;27(suppl 2):B22-B26. (Pubitemid 38569260)
13. Wu WC, Schifftner TL, Henderson WG, et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA. 2007;297(22):2481-2488. (Pubitemid 46953401)
14. Hamilton BH, Ko CY, Richards K, Hall BL. Missing data in the American College of Surgeons National Surgical Quality Improvement Program are not missing at random: implications and potential impact on quality assessments. J Am Coll Surg. 2010;210(2):125-139.
15. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-116. (Pubitemid 27089212)
16. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
17. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167(4):492-499. (Pubitemid 351264145)
18. Austin PC. Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007;134(5):1128-1135.
19. Austin PC. Optimal caliper widths for propensityscore matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161.
20. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
21. Agresti A, Min Y. Effects and non-effects of paired identical observations in comparing proportions with binary matched-pairs data. Stat Med. 2004;23(1):65-75. (Pubitemid 38072107)
22. Hamel MB, Henderson WG, Khuri SF, Daley J. Surgical outcomes for patients aged 80 and older: morbidity and mortality from major noncardiac surgery. J Am Geriatr Soc. 2005;53(3):424-429. (Pubitemid 41623520)
23. Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer RM Jr. Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1199-1210. (Pubitemid 46819087)
24. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology. 2011;114(4):796-806.
25. Devereaux PJ, Chan MT, Alonso-Coello P, et al Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307(21):2295-2304.
26. Poldermans D, Bax JJ, Schouten O, et al Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo Study Group. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? J Am Coll Cardiol. 2006;48(5):964-969. (Pubitemid 44292449)
27. Bertges DJ, Goodney PP, Zhao Y, et al Vascular Study Group of New England. The Vascular Study Group of New England Cardiac Risk Index (VSGCRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg. 2010;52(3):674-683, 683, e1-e683, e3.
28. Flu WJ, van Kuijk JP, Chonchol M, et al. Timing of pre-operative Beta-blocker treatment in vascular surgery patients: influence on post-operative outcome. J Am Coll Cardiol. 2010;56(23):1922-1929.
29. Ellenberger C, Tait G, Beattie WS. Chronic β blockade is associated with a better outcome after elective noncardiac surgery than acute β blockade: a single-center propensity-matched cohort study. Anesthesiology. 2011;114(4):817-823.
30. van Klei WA, Bryson GL, Yang H, Forster AJ. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty. Anesthesiology. 2009;111(4):717-724.
31. Wallace AW, Au S, Cason BA. Association of the pattern of use of perioperative β-blockade and post-operative mortality. Anesthesiology. 2010;113(4):794-805.
32. Kwon S, Thompson R, Florence M, et al Surgical Care and Outcomes Assessment Program (SCOAP) Collaborative. β-Blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program. Arch Surg. 2012;147(5):467-473.
33. Badgett RG, Lawrence VA, Cohn SL. Variations in pharmacology of beta-blockers may contribute to heterogeneous results in trials of perioperative beta-blockade. Anesthesiology. 2010;113(3):585-592.
34. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016.
35. Smith SC Jr, Benjamin EJ, Bonow RO, et al World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458- 2473.
36. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology. 2008;108(4):559-567. (Pubitemid 351440575)
37. Poldermans D, Schouten O, van Lier F, et al. Perioperative strokes and beta-blockade. Anesthesiology. 2009;111(5):940-945.
38. Bateman BT, Schumacher HC, Wang S, Shaefi S, Berman MF. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes. Anesthesiology. 2009;110(2):231-238.